Literature DB >> 1991839

Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.

B B Kahn1, G I Shulman, R A DeFronzo, S W Cushman, L Rossetti.   

Abstract

Evidence is emerging for a direct role of glucose, independent of changes in insulin, in the regulation of cellular glucose transport and glucose utilization in vivo. In this study we investigate potential cellular and molecular mechanisms for this regulatory effect of glucose by determining how normalization of glycemia without insulin therapy in diabetic rats influences 3-O-methylglucose transport and the expression and translocation of two genetically distinct species of glucose transporters (GTs) in adipose cells. These results are compared with alterations in glucose disposal in vivo measured by euglycemic clamp. In rats rendered diabetic by 90% pancreatectomy, insulin-stimulated glucose transport in adipose cells is decreased 50% in parallel with reduced insulin-mediated glucose disposal in vivo. Levels of adipose/muscle GTs measured by immunoblotting are decreased in adipose cell subcellular membrane fractions, as are the corresponding mRNA levels assessed by Northern blotting of total adipose cell RNA. Normalization of blood glucose in diabetic rats with phlorizin, which impairs renal tubular glucose reabsorption and thus enhances glucose excretion, restores insulin-stimulated glucose transport in adipose cells and insulin-mediated glucose disposal in vivo. Importantly, levels of the adipose/muscle GT protein remain 43% reduced in the low-density microsomes in the basal state and 46% reduced in the plasma membranes in the insulin-stimulated state. Adipose/muscle GT mRNA levels remain approximately 50% depressed. Levels of the HepG2/brain GT protein and mRNA are unaltered by diabetes or phlorizin treatment. Thus, changes in ambient glucose independent of changes in ambient insulin can regulate the glucose transport response to insulin in isolated adipose cells and changes in responsiveness parallel alterations in glucose uptake in vivo. Since this effect can occur without alteration in the expression of the two species of glucose transporters present in adipose cells or in their translocation to the plasma membrane in response to insulin, it may result from changes in GT functional activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991839      PMCID: PMC296344          DOI: 10.1172/JCI115031

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

1.  Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.

Authors:  H Fukumoto; T Kayano; J B Buse; Y Edwards; P F Pilch; G I Bell; S Seino
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

2.  Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations.

Authors:  A Zorzano; W Wilkinson; N Kotliar; G Thoidis; B E Wadzinkski; A E Ruoho; P F Pilch
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

3.  Insulin-stimulated translocation of glucose transport systems in the isolated rat adipose cell. Time course, reversal, insulin concentration dependency, and relationship to glucose transport activity.

Authors:  E Karnieli; M J Zarnowski; P J Hissin; I A Simpson; L B Salans; S W Cushman
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

4.  Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting.

Authors:  J Berger; C Biswas; P P Vicario; H V Strout; R Saperstein; P F Pilch
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

5.  Regulation of glucose transporter messenger RNA levels in rat adipose tissue by insulin.

Authors:  W I Sivitz; S L DeSautel; T Kayano; G I Bell; J E Pessin
Journal:  Mol Endocrinol       Date:  1990-04

6.  Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.

Authors:  W T Garvey; T P Huecksteadt; M J Birnbaum
Journal:  Science       Date:  1989-07-07       Impact factor: 47.728

7.  Regulation of glucose transporter messenger RNA in insulin-deficient states.

Authors:  W I Sivitz; S L DeSautel; T Kayano; G I Bell; J E Pessin
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.

Authors:  K H Kaestner; R J Christy; J C McLenithan; L T Braiterman; P Cornelius; P H Pekala; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Recovery of maximal insulin responsiveness and insulin sensitivity after induction of insulin resistance in primary cultured adipocytes.

Authors:  R R Traxinger; S Marshall
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

View more
  40 in total

Review 1.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

2.  Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport.

Authors:  Adam T Stearns; Anita Balakrishnan; Ali Tavakkolizadeh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

4.  In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.

Authors:  Kwang-Hoon Chun; Kang-Duk Choi; Dae-Ho Lee; Yoonshin Jung; Robert R Henry; Theodore P Ciaraldi; Young-Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

Review 5.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.

Authors:  B B Kahn
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 7.  Renal glucose transporters: novel targets for hyperglycemia management.

Authors:  Amanda Mather; Carol Pollock
Journal:  Nat Rev Nephrol       Date:  2010-03-30       Impact factor: 28.314

8.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.

Authors:  L Rossetti; M Hawkins; W Chen; J Gindi; N Barzilai
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.

Authors:  J Eriksson; L Koranyi; R Bourey; C Schalin-Jäntti; E Widén; M Mueckler; A M Permutt; L C Groop
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

Review 10.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.